Lung Infection

Evidence Poor for Accuracy of COVID-19 Serological Tests

Publish Date July 14, 2020

Evidence for diagnostic accuracy of COVID-19 serological tests characterized by high risks of bias and heterogeneity.

ACP Does Not Recommend Chloroquine, Hydroxychloroquine With or Without Azithromycin for COVID-19

By

Sweta Gupta

Publish Date July 14, 2020

The American College of Physicians does not recommend chloroquine or hydroxychloroquine, with or without azithromycin, as prophylaxis against or as treatment for COVID-19.

Cardiac Arrests, Arrhythmias in COVID-19 Also a Consequence of Systemic Illness

By

Brandon May

Publish Date July 14, 2020

Cardiac arrests and arrhythmias observed in patients with COVID-19 were found to result from infection by the virus as well as systemic conditions.

COVID-19 Cases in Spain Lower in Cystic Fibrosis vs General Population

By

Brandon May

Publish Date July 13, 2020

Patients with cystic fibrosis in Spain may have a lower incidence of COVID-19 as well as lower associated mortality compared with the general population.

NIH: New Network Aims to Enroll Thousands for COVID-19 Vaccine, Therapeutics Trials

By

Brian Park, PharmD

Publish Date July 13, 2020

The COVPN is part of “Operation Warp Speed”, a partnership led by the Department of Health and Human Services to accelerate the development, manufacturing, and distribution of COVID-19 vaccines, therapeutics, and diagnostics.

Point Prevalence Surveys in Skilled Nursing Facilities Can Lower COVID-19 Transmission

Publish Date July 13, 2020

Conducting point-prevalence surveys in skilled nursing facilities can inform infection prevention and control activities to reduce COVID-19 transmission.

Most Patients Using Online COVID-19 Tool Report Mild, Moderate Symptoms

Publish Date July 13, 2020

Self-assessment tool could ease burden on the healthcare system and collect useful information.

Study to Assess Antiviral Antibody Cocktail for COVID-19 Prevention Begins

By

Diana Ernst, RPh

Publish Date July 10, 2020

A phase 3 trial evaluating an investigational antiviral antibody cocktail, REGN-COV2, for the prevention of COVID-19 has been initiated by Regeneron Pharmaceuticals.

Outcomes Similar in COVID-19 for Patients With or Without HIV

Publish Date July 10, 2020

The rate of patients who required mechanical ventilation and died was similar between patients with HIV and matched comparators.

Siltuximab to Be Evaluated for COVID-19 Associated ARDS in Phase 3 Trial

By

Brian Park, PharmD

Publish Date July 9, 2020

Siltuximab is currently marketed under the trade name Sylvant and is indicated for the treatment of multicentric Castleman’s disease.

ASAIO Recommendations for Advanced Cardiopulmonary Support for Patients With COVID-19

By

Gary Rothbard, MD, MS

Publish Date July 9, 2020

Recommendations by ASAIO on selection and treatment of patients with respiratory and circulatory failure associated with COVID-19 using artificial pulmonary and/or cardiac support.